Biofrontera (BFRI) Debt to Equity: 2021-2024
Historic Debt to Equity for Biofrontera (BFRI) over the last 1 years, with Jun 2024 value amounting to $0.03.
- Biofrontera's Debt to Equity was N/A to $0.03 in Q2 2024 from the same period last year, while for Jun 2024 it was $1.26, marking a year-over-year change of. This contributed to the annual value of $0.81 for FY2023, which is 180.17% up from last year.
- Latest data reveals that Biofrontera reported Debt to Equity of $0.03 as of Q2 2024, which was up 106.24% from -$0.43 recorded in Q1 2024.
- Over the past 5 years, Biofrontera's Debt to Equity peaked at $6.95 during Q3 2023, and registered a low of -$0.43 during Q1 2024.
- Moreover, its 3-year median value for Debt to Equity was $0.29 (2022), whereas its average is $1.17.
- As far as peak fluctuations go, Biofrontera's Debt to Equity soared by 4,741.70% in 2023, and later tumbled by 203.58% in 2024.
- Over the past 4 years, Biofrontera's Debt to Equity (Quarterly) stood at $0.29 in 2021, then rose by 1.67% to $0.29 in 2022, then spiked by 180.17% to $0.81 in 2023, then tumbled by 203.58% to $0.03 in 2024.
- Its Debt to Equity was $0.03 in Q2 2024, compared to -$0.43 in Q1 2024 and $0.81 in Q4 2023.